Literature DB >> 9768951

Standardized clinical care pathways for major thoracic cases reduce hospital costs.

K J Zehr1, P B Dawson, S C Yang, R F Heitmiller.   

Abstract

BACKGROUND: Standardized clinical care pathways have been developed for postoperative management in an attempt to contain costs in an era of rising health care costs and limited resources. The purpose of this study was to assess the effect of these pathways on length of stay, hospital charges, and outcome for major thoracic surgical procedures.
METHODS: All anatomic lung (segmentectomy, lobectomy, and pneumonectomy) and partial and complete esophageal resections performed from July 1991 to July 1997 were retrospectively analyzed for length of stay, hospital charges, and outcome. A prospectively developed database was used. Clinical care pathways were introduced in March 1994. Comparisons were made between the procedures performed before (group I) and after (group II) pathway implementation. Common to both pathways are early mobilization and prudent x-ray and laboratory analysis. In addition, the pathway for esophagectomies emphasizes overnight intubation with 24-hour intensive care unit care, and staged diet advancement. The discharge goal was postoperative day 10. For lung resection the emphasis is early postoperative extubation with overnight intensive care unit management. The discharge goal was postoperative day 7.
RESULTS: Group I esophagectomies (n = 56) had significantly greater hospital charges compared with group II (n = 96) ($21,977 +/- $13,555 versus $17,919 +/- $5,321; p < 0.04, in actual dollars) and ($29,097 +/- $18,586 versus $19,260 +/- $6,000; p < 0.001, in dollars adjusted for inflation) and greater length of stay (13.6 +/- 6.9 versus 9.5 +/- 2.8 days; p < 0.001). Group I lung resections (n = 185) had a significantly greater length of stay compared with group II (n = 241) (8.0 +/- 6.2 versus 6.4 +/- 3.8 days; p < 0.002); although charges trended downward ($13,113 +/- $10,711 versus $12,404 +/- $7,189; not significant) in actual dollars, charges were significantly less in dollars adjusted for inflation ($17,103 +/- $13,211 versus $13,432 +/- $8,056; p < 0.01). The most significant decreases in charges for esophagectomies were in miscellaneous charges (61% in dollars adjusted for inflation), pharmaceuticals (60%), laboratory (42%) and radiologic (39%) tests, physical therapy charges (35%), and routine charges (34%). For lung resections the greatest savings occurred for pharmaceuticals (38%), supplies (34%), miscellaneous charges (25%), and routine charges (22%). Mortality was similar (esophagectomies: I, 3.6%; II, 0%; lung resections: I, 0.5%; II, 0.8%; not significant).
CONCLUSIONS: Introduction of standardized clinical pathways has resulted in a marked reduction of length of stay for all major thoracic surgical procedures. Total charges were reduced for both esophagectomies (34%) and lung resections (21%) with continued quality of outcome.

Mesh:

Year:  1998        PMID: 9768951     DOI: 10.1016/s0003-4975(98)00662-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  32 in total

1.  Critical pathway effectiveness: assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis.

Authors:  Sydney M Dy; Pushkal Garg; Dorothy Nyberg; Patricia B Dawson; Peter J Pronovost; Laura Morlock; Haya Rubin; Albert W Wu
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

2.  Establishment of a clinical pathway as an effective tool to reduce hospitalization and charges after video-assisted thoracoscopic pulmonary resection.

Authors:  Riichiroh Maruyama; Tetsuro Miyake; Miyako Kojo; Yoshiro Aoki; Ryuichi Suemitsu; Tatsuro Okamoto; Hiroshi Wataya; Yukito Ichinose
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-09

Review 3.  Clinical Pathways in surgery: should we introduce them into clinical routine? A review article.

Authors:  Ulrich Ronellenfitsch; Eric Rössner; Jens Jakob; Stefan Post; Peter Hohenberger; Matthias Schwarzbach
Journal:  Langenbecks Arch Surg       Date:  2008-02-23       Impact factor: 3.445

Review 4.  Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery.

Authors:  Ines Gockel; Constantin Johannes Ahlbrand; Michael Arras; Elke Maria Schreiber; Hauke Lang
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

5.  Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care.

Authors:  Lihong Wang; Chenjing Zhu; Xuelei Ma; Kai Shen; Hongmei Li; Yuanyuan Hu; Linghong Guo; Jing Zhang; Ping Li
Journal:  Support Care Cancer       Date:  2016-10-10       Impact factor: 3.603

Review 6.  Clinical pathway for thoracic surgery in an Italian centre.

Authors:  Majed Refai; Michele Salati; Michela Tiberi; Armando Sabbatini; Paolo Gentili
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

7.  Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.

Authors:  Donald E Low; Sonia Kunz; Drew Schembre; Henry Otero; Tom Malpass; Alex Hsi; Guobin Song; Richard Hinke; Richard A Kozarek
Journal:  J Gastrointest Surg       Date:  2007-08-31       Impact factor: 3.452

8.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

9.  Effects of a clinical pathway for video-assisted thoracoscopic surgery (VATS) on quality and cost of care.

Authors:  Matthias H M Schwarzbach; Ulrich Ronellenfitsch; Qian Wang; Eric D Rössner; Christof Denz; Stefan Post; Peter Hohenberger
Journal:  Langenbecks Arch Surg       Date:  2009-06-10       Impact factor: 3.445

10.  Impact of hospital teaching status on survival from ruptured abdominal aortic aneurysm repair.

Authors:  Robert A Meguid; Benjamin S Brooke; Bruce A Perler; Julie A Freischlag
Journal:  J Vasc Surg       Date:  2009-05-15       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.